{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-09",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "0078-0563",
      "generic_name": "amlodipine valsartan and hydrochlorothiazide",
      "labeler_name": "Novartis Pharmaceuticals Corporation",
      "brand_name": "Exforge HCT",
      "active_ingredients": [
        {
          "name": "AMLODIPINE BESYLATE",
          "strength": "10 mg/1"
        },
        {
          "name": "VALSARTAN",
          "strength": "320 mg/1"
        },
        {
          "name": "HYDROCHLOROTHIAZIDE",
          "strength": "25 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "0078-0563-15",
          "description": "30 TABLET, FILM COATED in 1 BOTTLE (0078-0563-15)",
          "marketing_start_date": "20090404",
          "sample": false
        }
      ],
      "listing_expiration_date": "20261231",
      "openfda": {
        "manufacturer_name": [
          "Novartis Pharmaceuticals Corporation"
        ],
        "rxcui": [
          "848131",
          "848134",
          "848135",
          "848139",
          "848140",
          "848144",
          "848145",
          "848149",
          "848151",
          "848155"
        ],
        "spl_set_id": [
          "18d7820d-471f-4ee2-9ec6-25d8d27c77de"
        ],
        "is_original_packager": [
          true
        ],
        "nui": [
          "N0000175359",
          "N0000175419",
          "M0471776",
          "N0000000070",
          "N0000175561"
        ],
        "pharm_class_pe": [
          "Increased Diuresis [PE]"
        ],
        "pharm_class_epc": [
          "Thiazide Diuretic [EPC]",
          "Angiotensin 2 Receptor Blocker [EPC]"
        ],
        "pharm_class_cs": [
          "Thiazides [CS]"
        ],
        "pharm_class_moa": [
          "Angiotensin 2 Receptor Antagonists [MoA]"
        ],
        "unii": [
          "0J48LPH2TH",
          "864V2Q084H",
          "80M03YXJ7I"
        ]
      },
      "marketing_category": "NDA",
      "dosage_form": "TABLET, FILM COATED",
      "spl_id": "e10fea42-c6e7-4584-9a0a-0709c5323cd8",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20090404",
      "product_id": "0078-0563_e10fea42-c6e7-4584-9a0a-0709c5323cd8",
      "application_number": "NDA022314",
      "brand_name_base": "Exforge HCT",
      "pharm_class": [
        "Angiotensin 2 Receptor Antagonists [MoA]",
        "Angiotensin 2 Receptor Blocker [EPC]",
        "Calcium Channel Antagonists [MoA]",
        "Calcium Channel Blocker [EPC]",
        "Cytochrome P450 3A Inhibitors [MoA]",
        "Dihydropyridine Calcium Channel Blocker [EPC]",
        "Dihydropyridines [CS]",
        "Increased Diuresis [PE]",
        "Thiazide Diuretic [EPC]",
        "Thiazides [CS]"
      ]
    }
  ]
}